Normal Goat Serum from Calbiochem
Rabbit Anti-ZFP-38 / RU49 Polyclonal Antibody, Unconjugated from CeMines
X-Gal Solution from Novagen
Total Protein Western Blots - Plant Normal Tissue, Blot I from BioChain
Biology Products:(Date:11/6/2009)...ll/ - Microbix Biosystems Inc. (the "Company") ann...1 Certification of Annual Filings of William Gastl... Chief Financial Officer (the "Officer,s Certifica...e annual audited financial statements for the year...ally filed the annual financial statements for the...
(Date:11/6/2009)...-- Myriant Technologies LLC ("Myriant"), a private...newable bio-chemicals, Uhde Corporation of America...one of the world,s leading engineering contractors...ngineering, procurement & construction (EPC) o... renewable feedstocks. The execution of this alli...
(Date:11/6/2009)...wswire/ -- Calbiotech, Inc. announced today that i...earch (SBIR) Phase I contract by the U.S. Army Med... the agreement, Calbiotech will develop analyte sp... virus. ,, Dengue virus is a mosquito-born f...ry forces deployed to tropical areas of the world....
(Date:11/6/2009)...Arrowhead’s 2010 Personalized Medicine Partn...February 22-24, 2010 in Philadelphia, has been ann...ight key issues in forming partnerships and engage... Minneapolis, MN (PRWEB) No... 2010 Personalized Medicine Partnerships Conferen...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3